GGrantIndex
Sort

39,280 grants matching leukemia

Investigating the link between DNA damage, chromatin and nuclear dysfunction

$770,054
Philipp Oberdoerffer · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Role of Natural Pseudotyping with Other Viruses in HIV Transmission

$770,000
James E.k Hildreth · University Of California At Davis · DP1 · FY2014 · AI

Role of Natural Pseudotyping with Other Viruses in HIV Transmission

$770,000
James E.k Hildreth · University Of California At Davis · DP1 · FY2015 · AI

Collaborative Human Tissue Network (CHTN)

$769,787
Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · UM1 · FY2018 · CA

Regulation of mRNA processing: Mechanisms and consequences

$768,910
James L. Manley · Columbia Univ New York Morningside · R35 · FY2016 · GM

Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy

$768,857
Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Screening for Inhibitors of the Chromatin Reader SGF29

$768,437
Aniruddha J. Deshpande · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA

Role of Natural Pseudotyping with Other Viruses in HIV Transmission

$767,750
James E.k Hildreth · University Of California At Davis · DP1 · FY2011 · OD

Comprehensive Interrogation of Toxicity Profiles Associated with Novel CAR T-cell Constructs

$767,708
Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Development of Novel Immunotherapeutic Strategies for Myeloid Malignancies

$767,708
Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Signal Transduction Therapy--Clinical

$767,604
Elise C. Kohn · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

Identifying the mechanisms of leukemia progression

$767,359
John D Crispino · St. Jude Children'S Research Hospital · R35 · FY2024 · CA

Immunotherapeutic targeting of gangliosides in Ewing Sarcoma

$767,167
Robbie G. Majzner · Dana-Farber Cancer Inst · U01 · FY2025 · CA

Preventing GVHD by inhibition of alloantigen presentation in the gut

$766,705
Geoffrey Roger Hill · Fred Hutchinson Cancer Research Center · R01 · FY2019 · HL

FANCONI ANEMIA:GENOTYPE-PHENOTYPE CORRELATIONS

$766,684
Elaine Ostrander · National Human Genome Research Institute · ZIA · FY2013 · HG

Gene editing ELANE to understand and treat severe congenital neutropenia

$766,145
Daniel Evan Bauer · Boston Children'S Hospital · R01 · FY2023 · HL

Phase I Clinical Trials of Anti-Cancer Agents

$766,143
Mark J Ratain · University Of Chicago · U01 · FY2008 · CA

Role of Trk Receptors in the Development and Function of Non-neuronal Structures

$766,137
Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy

$766,002
Daniel Fowler · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA

Tissue Core

$765,719
Laura Z Rassenti · University Of California, San Diego · P01 · FY2010 · CA

Biological Functions of Chromosomal Proteins

$765,529
Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Indiana University Center for Pediatric Pharmacology

$765,284
Jamie L Renbarger · Indiana University Indianapolis · U54 · FY2012 · HD

Glucocorticoids and T cell development and function

$764,931
Jonathan Ashwell · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Mechanisms of coagulopathy and bleeding in acute promyelocytic leukemia

$764,817
Yohei M Hisada · Univ Of North Carolina Chapel Hill · R56 · FY2024 · HL

The Family Bridge Program to Address Communication and Navigation-Related Inequities for Minority Children and Families: A Randomized Controlled Trial

$764,438
Katherine Casey Lion · Seattle Children'S Hospital · R01 · FY2022 · MD